NEW APPLICATIONS FOR THE PATENTS - IPO Pakistan

NEW APPLICATIONS FOR THE PATENTS
The dates shown in the crescent brackets are the dates claimed under section 86 of the
Patents Ordinance 2000.
24-01-2005
41/2005 Merck Sharp & Dohme Limited,
UK,
(Priority 30-1-04 GB)
42/2005 Hatch Tech Group B.V,
The Netherlands,
(Priority 23-1-04 The Netherlands)
25-01-2005
43/2005 Aventis Pharma Deutschland GmbH,
Germany,
(Priority 25-1-04 Germany)
44/2005 Aventis Pharma Deutschland GmbH,
Germany,
(Priority 25-1-04 Germany)
45/2005 Telenor ASA,
Norway,
(Priority 26-1-04 Norway)
46/2005 1. ENI S.p.A, Italy and
2. Enitecnologie S.P.A, Italy,
(Priority 5-2-04 Italy)
“ Polymorphic forms of a GABAA
agonist “
“ Method for holding poikilothermic
poultry, and device for holding
poikilothermic poultry “
“ Aryl-substituted heterocycles process
for their preparation and their use as
medicaments “
“ Substituted
N-cyclohexylimidazolinones, process
for their preparation and their use as
medicaments “
“ Method and device for conditional
forwarding of IM message “
“ Process for the removal of hydrogen
sulfide by means of its oxidation in the
presence of hetero polyacids “
47/2005 Unilever PLC,
England,
(Priority 6-2-04 India)
48/2004 Astra Zeneca AB,
Sweden,
(Priority 6-2-04 Sweden)
26-01-2005
49/2005 DE Nora Elettrodi S.p.A,
Italy,
(Priority 28-1-04 USA)
“ Improved detergent composition “
“ New pyridin-2- One compounds
useful as inhibitors of thrombin “
“ Synthesis of noble metal sulphide
catalysts in a sulphide ion-free aqueous
environment “

50/2005 Danisco A/S,
Denmark,
(Priority 28-1-04 USA)
51/2005 Astra Zeneca AB,
Sweden,
(Priority 3-2-04 EPO)
52/2005 Astra Zeneca AB,
Sweden,
(Priority 3-2-04 GB)
53/2005 Honda Motor Co, Ltd,
Japan,
(Priority 5-2-04 Japan)
27-01-2005
54/2005 Aventis Pharma Deutschland GmbH,
Germany,
(Priority 3-3-04 EPO)
55/2005 Astra Zeneca AB,
Sweden,
(Priority 2-2-04 Sweden)
28-01-2005
56/2005 Novartis AG,
Switzerland,
(Priority 29-1-04 USA)
57/2005 Astra Zeneca AB,
Sweden,
(Priority 10-2-04 Sweden)
58/2005 Reckitt Benckiser (Australia ) Pty
Limited,
Australia.
(Priority 30-1-04 GB)
59/2005 Otsuka Pharmaceutical Co, Ltd,
Japan,
(Priority 18-2-04 Japan)
“ Baked product with increased shelf life
and process for increasing the shelf life
of baked products “
“ Quinazoline derivatives “
“ Chemical Compounds”
“ Loading-platform mounting structure “
“ Beta – aminoacid – derivatives as
factor Xa inhibitors “
“ Chemical Compounds “
“ Pyrrolo pyrimidine derivatives useful
for treating proliferative diseases “
“ Novel Compounds “
“ Prodenticide “
“ Method for producing
4-nitroimidazole compound “

APPLICATION ACCEPTED
Notice is hereby given that the person interested in opposing the grant of Patents to any of
the applications referred to below at any time within four months from the date of this
Gazette may given notice at the Patent Office on the prescribed Form P-7 of the Patents
Rules 18(1) of 2003.
The six figures number shown in the right hand side are those given to applications on
acceptance of the complete specification under which the specification will be printed and
subsequent proceeding taken.
The figures shown within square brackets after the title of inventions indicated their
classification index at acceptance.
Typed copies of the specification which are to open to public inspection can be supplied
by the Patent Office on payment of the prescribed charges which may be as certained on
application to the office.
342/2003 Magna Force, Inc.
U.S.A.
“Apparatus, systems and methods for levitating and
moving objects”
(Class: B65G, 51/00)
138526
Comprises a track having a length, an object
configured to travel along the track, a drive rail system
and at least one driving disc coupled to said object to
rotate about a rotary axis with respect to the object.
364/2003 MIDI-Motor Development
International S.A.
Luxembourg
“Motor-driven compressor-alternator unit with
additional compressed air injection operating with
mono and multiple energy”
(Class: F02B, 57/10)
138527
Characterized in that the pistons have two stages of
diameter i.e. a larger and a smaller the secone one
being used for the expansion function with work in the
ambient thermal energy recovery system.

376/2003 E.I. Du Pont De Nemours
and Company,
U.S.A.
“Process for the production of terephthalic acid”
(Class: C07C, 51/16)
138528
A process for the production of carboxylic acid or its
eater by catalytic liquid phase oxidation, of
corresponding precursor in acetic acid as solvent.
383/2003 Desal LLC.
U.S.A.
“Process and structure for super accelerating nature,
producing a continuous supply of fresh water from salt
water by using solar, wind and wave energy”
(Class: C02F, 1/14)
138529
Process for desalinizing water comprising the steps of
providing a blackened surface in contact with water,
channeling heated water vapor and air upward through
a vertical venture wind shaft creating an adiabatic
pressure variance to release water vapor into a first
chamber of a series thereof.
391/2003 1. Verdia, Inc.
U.S.A.
2. Pioneer Hi-Bred
International, Inc.
U.S.A.
“Novel glyphosate N-acetyl transferase (GAT) genes”
(Class: INT.CL. C12N, 15/29, A61K, 38/43)
138530
Comprises novel proteins, including protein capable of
catalyzing the acetylation of glyphosate and other
structurally related proteins, novel polynuclectides
capable of encoding these proteins compositions
containing them can be used to render an organism,
such as plant, resistant to glyphosate.
641/2003 Glaxo Group Limited,
U.K.
“An aerosol dentifrice composition”
(Class: A61K, 7/16)

138531
Comprising water, a particulate abrasive and a
propellant characterized in that the propellant
comprises 2-8 wt % of a non-hydrocarbon and 2-6 wt
% of a hydro carbon propellant.
653/2003 Pharmacia Corporation,
U.S.A.
“Sustained-release tablet composition of pramipexole”
(Class: A61K, 31/554)
138532
Comprising water saluble salt of prompexole,
dispensed in 2 matrix comprising a hydrophilic
polymer and a starch having a tensor strength of at
least about 0.15 KN CM-2 preferably at least about
0.175 KN CM-2, and more preferably at least about
0.2 KN CM-2, at a solid fraction representative of the
tablet.
671/2003 Delta Innovations Limited,
Karachi, Pakistan
“An improved pollution-free tri-wheeler vehicle”.
(Class: B62D, 31/00)
138533
Comprises a main body, a self-start four stroke engine,
said body having a space for passengers, the engine
being a 150 cc water cooled engine having a dual
exhaust and an electrically operated screen wiper and a
gear shaft lever.
693/2003 AstraZeneca UK Limited,
U.K.
“Process for the manufacture of
(E)-7[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methy
lsulfonyl)amino] pyrimidin-5-yl](3R, 5S)-3,
5-dihydroxyhept-6-enoic acid calcium salt”
(Class: C07D, 239/69)
138534
Comprises mixing of a solution of calcium chloride
with a solution of water soluble salt of (E)-7-[4-(4-
fluorophenyl)-6-isopropyl-2-[methyl(methyl sulfonyl)
amino] pyrimidine 5-yl] (3R,5S)-3, 5
dihydroxyhept-6-enoic acid, wherein the process

parameters are selected to give a product which
demonstrates improved efficiency of filtration.
SEALING FEES DUE
Notice is hereby given that the Patent may now be sealed on the application referred to
below if it is desired that Patent should be sealed a request on the prescribed Form-8
accompanied by the fee of Rs.2250/- should be sent to the Controller of Patents and
Designs, The Patent Office, Karachi.
138394 HF Arzneimittelforschung GmbH,
Germany
138395 Chiesi Framaceutici S.p.A.,
Italy
138396 Pfizer Inc.,
U.S.A.
138397 BP Chemicals Limited,
England
138398 Alizyme Therapeutics Limited,
U.K.
1114/2002
1119/2002
50/2003
88/2003
110/2003
(Mrs. Yasmeen Abbasi)
Controller of Patents & Designs
Tel: 9215488